Lonza | LONN - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akzo Nobel EUR 2.13B 23M 2026-03
Alcon AG USD 2.41B 4M 2026-03
Almirall EUR 517.4M 32K 2025-12
AstraZeneca USD 8.18B 4.35B 2026-03
BASF EUR 14.62B 410M 2026-03
Bayer EUR 9.88B 452M 2026-03
Beiersdorf EUR 4.16B 212M 2025-12
Covestro EUR 3.24B 5.46B 2025-12
Demant DKK 9.63B 241M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.34B 63M 2026-03
Geberit CHF 581.3M 1.3M 2025-12
Genmab DKK 798M 235M 2025-12
Givaudan CHF 3B 107M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GN Store Nord DKK 2.16B 1.94B 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Johnson Matthey GBP 7.02B 1.81B 2026-06
Merck EUR 4.09B 687M 2026-03
Novartis USD 9.29B 507M 2026-03
Philips EUR 3.6B 775M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Sika AG CHF 4.8B 78.3M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Solvay EUR 1.02B 10M 2026-03
UCB EUR 2.96B 196M 2025-12